Sarepta Therapeutics Inc SRPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
83.81quote price arrow down-0.98 (-1.16%)
Volume
17,251
Close
84.79quote price arrow up+2.63 (+3.20%)
Volume
1,757,276
52 week range
77.01 - 181.83

...

Loading . . .

KEY STATS

  • Open83.00
  • Day High85.49
  • Day Low78.31
  • Prev Close82.16
  • 52 Week High181.83
  • 52 Week High Date12/22/20
  • 52 Week Low77.01
  • 52 Week Low Date02/23/21
  • Market Cap6.734B
  • Shares Out79.42M
  • 10 Day Average Volume1.65M
  • Dividend-
  • Dividend Yield-
  • Beta1.63
  • 1 Year % Change-27.59

RATIOS/PROFITABILITY

  • EPS (TTM)-7.07
  • P/E (TTM)-12.00
  • Fwd P/E (NTM)-11.42
  • EBITDA (MRQ)-537.252M
  • ROE (MRQ)-70.15%
  • Revenue (MRQ)540.10M
  • Gross Margin (MRQ)88.26%
  • Net Margin (MRQ)-102.60%
  • Debt To Equity (MRQ)130.29%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Sarepta Therapeutics Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of rare neuromuscular diseases. It operates through discovering, developing, manufacturing and delivering therapies to patients with Duchenne muscular dystrophy (DMD). It is focused on the development of its disease-modifying DMD drug candidates. It has received accelerated approval for its...
M. Kathleen Behrens Ph.D.
Chairman
Douglas Ingram Esq., J.D.
President
Ian Estepan
Chief Financial Officer
Alexander Cumbo
Executive Vice President
William Ciambrone
Executive Vice President
Ryan Brown
General Counsel
Address
215 1st St Ste 415
Cambridge, MA
02142-1213
United States